Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome

Bempedoic acid is a new cholesterol-lowering drug, which has recently received US FDA and EMA approval. This drug targets lipid and glucose metabolism as well as inflammation via downregulation of ATP-citrate lyase and upregulation of AMP-activated protein kinase (AMPK). The primary effect is the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Biolo, Gianni, Vinci, Pierandrea, Mangogna, Alessandro, Landolfo, Matteo, Schincariol, Paolo, Fiotti, Nicola, Mearelli, Filippo, Di Girolamo, Filippo Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650075/
https://www.ncbi.nlm.nih.gov/pubmed/36386319
http://dx.doi.org/10.3389/fcvm.2022.1028355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650075/
https://www.ncbi.nlm.nih.gov/pubmed/36386319
http://dx.doi.org/10.3389/fcvm.2022.1028355

Ejemplares similares